Eyes not solely let us enjoy the magnificence around
us but additionally assist doctors diagnose a variety of well being points
corresponding to Parkinsonβs disease. Reportedly, in Parkinsonβs
illness alone, one out of 4 patients are misdiagnosed and wait an average of
13 months to receive a diagnosis. By this time, they'd have misplaced 65% of dopamine-producing neurons.
Preventing this situation, French-Belgian medtech startup
neuroClues (previously generally known as P3Lab), is building accessible, excessive-velocity eye-monitoring expertise
with AI-driven evaluation. Clues has just closed a β¬5 million pre-Series
A funding spherical led by White Fund and
the European Commissionβs EIC Accelerator program.
With this funding spherical, the startup could have raised a total funding of β¬12
million. This funding will allow the startup, incubated at iPEPS, the ParisSalpΓͺtriΓ¨re
Incubator, to increase into European and North American markets.
Founded by Antoine Pouppez and Pierre Daye, neuroClues is growing a medical machine
primarily based on eye-tracking to help in the early
analysis of neurological diseases.
|
:::
Angezeigte Eintrδge: 901 bis 910 von 5333 ::: 
Nδchste Seite
